Family Medicine · Yuba City, CA
NPI
1356442032
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
5
Hospital affiliations
1085 Gray Ave
Yuba City, CA, 95991
Phone (530) 755-1007
Medicare paid, 2024
$557K
11,112 services
Medicare patients, 2024
702
Average age 75
Drug cost, 2024
$2.9M
14,314 prescriptions
Company payments, 2025
$21K
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald D Hart was code 99214 (office e&m - established), 3,095 times for 639 patients. In total Ronald D Hart billed 11,112 services in 64 codes, and Medicare paid $557K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 3,095 | 639 | $92.06 | $285K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 2,983 | 577 | $40.45 | $121K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,244 | 69 | $0.23 | $288 |
| 99213 Office E&M - Established | Office | 1,219 | 475 | $70.18 | $86K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 733 | 117 | $0.32 | $234 |
| 96372 Injection Administration | Office | 398 | 155 | $10.60 | $4,217 |
| 81002 Clinical Chemistry | Office | 272 | 139 | $3.41 | $928 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 212 | 212 | $130.69 | $28K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 172 | 38 | $0.72 | $124 |
| 99212 Office E&M - Established | Office | 160 | 112 | $41.73 | $6,677 |
| 17003 Destruction Skin Lesion | Office | 81 | 15 | $5.62 | $455 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 79 | 27 | $0.91 | $71.55 |
| 93000 Electrocardiogram | Office | 72 | 64 | $10.64 | $766 |
| 99204 Office E&M - New | Office | 54 | 54 | $100.23 | $5,412 |
| 20610 Joint Injection | Office | 33 | 24 | $47.37 | $1,563 |
By year: 2022 $586K for 9,095 services; 2023 $664K for 11,246 services; 2024 $557K for 11,112 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 272 | 139 | $3.41 | $928 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronald D Hart prescribed most often to Medicare patients was Ezetimibe, with 1,100 prescriptions and refills. In total Ronald D Hart wrote 14,314 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ezetimibe Generic | 1,100 | 2,893 | 365 | $37K |
| Rosuvastatin Calcium Generic | 960 | 2,411 | 297 | $16K |
| Levothyroxine Sodium Generic | 745 | 1,903 | 199 | $8,811 |
| Farxiga Dapagliflozin Propanediol | 471 | 927 | 130 | $502K |
| Atorvastatin Calcium Generic | 448 | 1,268 | 143 | $4,290 |
| Ozempic Semaglutide | 394 | 472 | 68 | $418K |
| Amlodipine Besylate Generic | 390 | 945 | 113 | $1,870 |
| Valsartan Generic | 304 | 644 | 91 | $6,363 |
| Bisoprolol Fumarate Generic | 300 | 735 | 106 | $6,821 |
| Losartan Potassium Generic | 291 | 797 | 93 | $3,173 |
| Irbesartan Generic | 275 | 690 | 80 | $4,580 |
| Azithromycin Generic | 270 | 270 | 202 | $1,642 |
| Duloxetine Hcl Generic | 269 | 555 | 77 | $8,499 |
| Gabapentin Generic | 254 | 453 | 80 | $4,901 |
| Repatha Sureclick Evolocumab | 228 | 404 | 51 | $226K |
Brand drugs: 3,137 claims; generic drugs: 11,099 claims; opioid claims: 189.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald D Hart $21K ($21K in general payments such as food, travel and fees) from 33 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $16K.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 25 | $16K |
| Abbvie Inc. ABBV | 37 | $672 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 19 | $519 |
| AstraZeneca Pharmaceuticals LP AZN | 19 | $491 |
| Amgen Inc. AMGN | 27 | $450 |
| Novartis Pharmaceuticals Corporation NVS | 16 | $416 |
| Merck Sharp & Dohme LLC MRK | 12 | $265 |
| Novo Nordisk Inc NVO | 12 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $184 |
| GlaxoSmithKline, LLC. GSK | 11 | $182 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.